BioPharmX Public

BioPharmX is an organization that provides innovative drug-delivery products through its patented platform technologies for pharmaceutical and over-the-counter (OTC) applications. They focus on addressing unmet needs in large, well-defined, and under-served markets in the fast-growing health and wellness industry, particularly in dermatology, women's health, and Ear, Nose, and Throat (ENT) therapy. The company is led by a management team consisting of Silicon Valley executives, scientists, and business professionals with expertise in drug delivery and molecular properties. They have extensive experience in preclinical and clinical development, as well as regulatory compliance. BioPharmX aims to revolutionize drug delivery and improve patient outcomes in various therapeutic areas.

Last Funding Type: Series A
Last Funding Date: 2015-03-18
Funding Status: IPO
Headquarters: Menlo Park, California, United States
Industry: PharmTech
Estimated Revenue: Less than $1M
Technology: Cancer
Total Funding: $20 369 775
Employee Number: 11-50
Founded Date: 2011